BUB1B and cholangiocarcinoma: The survival time of patients with CCA with a high expression of BubR1 (98/189 cases, 51.9%) was significantly shorter than those with low BubR1 expression (91/189 cases, 48.1%; p < 0.05; Figure 2E).